Skip to main content

Advertisement

SpringerLink
Log in

Seeking a radiobiological explanation for thyroid stunning

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sabri O, Zimny M, Schreckenberger M, et al. Does thyroid stunning exist? A model with benign diseases. Eur J Nucl Med 2000; 27:1591–1597.

    Article  CAS  PubMed  Google Scholar 

  2. Huic D, Medvedec M, Dodig D, et al. Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose I-131. Nucl Med Commun 1996; 17:839–842.

    Article  CAS  PubMed  Google Scholar 

  3. McDougall IR. 74 MBq radioiodine I-131 does not prevent uptake of therapeutic doses of I-131 (i.e. it does not cause stunning) in differentiated thyroid cancer. Nucl Med Commun 1997; 18:505–512.

    Article  CAS  PubMed  Google Scholar 

  4. Leger FA, Izembart M, Dagousset F, et al. Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma. Eur J Nucl Med 1998; 25:242–246.

    Article  CAS  PubMed  Google Scholar 

  5. Cholewinski SP, Yoo KS, Klieger PS, et al. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq I-131. J Nucl Med 2000; 41:1198–1202.

    CAS  PubMed  Google Scholar 

  6. Jeevanram RK, Shah DH, Sharma SM, et al. Influence of large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Nucl Med Biol 1986; 13:277–279.

    CAS  Google Scholar 

  7. Medvedec M, Grosev D, Loncaric S, et al. Thyroid 'stunning': full-quantitative explanation based on radiation absorbed dose analysis [abstract]. Eur J Nucl Med 2000; 27:923.

    Google Scholar 

  8. Grosev D, Medvedec M, Loncaric S, et al. Determination of small objects from pinhole scintigrams. Nucl Med Commun 1998; 19:679–688.

    Article  CAS  PubMed  Google Scholar 

  9. Hall EJ. Radiation dose-rate: a factor of importance in radiobiology and radiotherapy. Br J Radiol 1972; 45:81–97.

    Article  CAS  PubMed  Google Scholar 

  10. Samuel AM, Rajashekharrao B. Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery. J Nucl Med 1994; 35:1944–1950.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Radiation Protection, University Hospital Rebro, Kispaticeva 12, 10000, Zagreb, Croatia

    Mario Medvedec

Authors
  1. Mario Medvedec
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Medvedec.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Medvedec, M. Seeking a radiobiological explanation for thyroid stunning. Eur J Nucl Med 28, 393–394 (2001). https://doi.org/10.1007/s002590000466

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590000466

Keywords

Search

Navigation